Related references
Note: Only part of the references are listed.Experimental Evolution Identifies Adaptive Aneuploidy as a Mechanism of Fluconazole Resistance in Candida auris
Jian Bing et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Colonisation and Transmission Dynamics of Candida auris among Chronic Respiratory Diseases Patients Hospitalised in a Chest Hospital, Delhi, India: A Comparative Analysis of Whole Genome Sequencing and Microsatellite Typing
Anamika Yadav et al.
JOURNAL OF FUNGI (2021)
Clade-specific chromosomal rearrangements and loss of subtelomeric adhesins in Candida auris
Jose F. Munoz et al.
GENETICS (2021)
Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris
Jeffrey M. Rybak et al.
MBIO (2020)
Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses
Nancy A. Chow et al.
MBIO (2020)
Molecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait
Wadha Alfouzan et al.
JOURNAL OF FUNGI (2020)
Amphotericin B and Other Polyenes-Discovery, Clinical Use, Mode of Action and Drug Resistance
Hans Carolus et al.
JOURNAL OF FUNGI (2020)
Pan-resistant Candida auris: New York subcluster susceptible to antifungal combinations
Brittany O'Brien et al.
LANCET MICROBE (2020)
Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast
Ryan Kean et al.
JOURNAL OF FUNGI (2020)
Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance
Patricia Escandon et al.
CLINICAL INFECTIOUS DISEASES (2019)
Candida auris: The recent emergence of a multidrug-resistant fungal pathogen
Kaitlin Forsberg et al.
MEDICAL MYCOLOGY (2019)
Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris
Jeffrey M. Rybak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping
Yong Jun Kwon et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris
Rory M. Welsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance
Sang Hu Kim et al.
MBIO (2019)
Finding the needle in a haystack: Mapping antifungal drug resistance in fungal pathogen by genomic approaches
Dominique Sanglard
PLOS PATHOGENS (2019)
Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria
Mark J. Biagi et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
The LUFS domain, its transcriptional regulator proteins, and drug resistance in the fungal pathogen Candida auris
Elizabeth Misas et al.
PROTEIN SCIENCE (2019)
FLO8 deletion leads to azole resistance by upregulating CDR1 and CDR2 in Candida albicans
Wen-Jing Li et al.
RESEARCH IN MICROBIOLOGY (2019)
Candida auris and multidrug resistance: Defining the new normal
Shawn R. Lockhart
FUNGAL GENETICS AND BIOLOGY (2019)
Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris
Farid Chaabane et al.
FRONTIERS IN MICROBIOLOGY (2019)
Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
Pedro Pais et al.
MICROBIAL CELL (2019)
Potential Fifth Clade of Candida auris, Iran, 2018
Nancy A. Chow et al.
EMERGING INFECTIOUS DISEASES (2019)
Gene Duplication Associated with Increased Fluconazole Tolerance in Candida auris cells of Advanced Generational Age
Somanon Bhattacharya et al.
SCIENTIFIC REPORTS (2019)
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris
Milena Kordalewska et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS)
A. Kritikos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance
Anuradha Chowdhary et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Limited ERG11 Mutations Identified in Isolates of Candida au ris Directly Contribute to Reduced Azole Susceptibility
Kelley R. Healey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ewa Ksiezopolska et al.
GENES (2018)
Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species
Jose F. Munoz et al.
NATURE COMMUNICATIONS (2018)
Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients
Gwenole Prigent et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Shawn R. Lockhart et al.
CLINICAL INFECTIOUS DISEASES (2017)
Mismatch Repair of DNA Replication Errors Contributes to Microevolution in the Pathogenic Fungus Cryptococcus neoformans
Kylie J. Boyce et al.
MBIO (2017)
Emergence of Echinocandin Resistance Due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis
Cristina Jimenez-Ortigosa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis
Jeffrey M. Rybak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Toward a quantitative understanding of antibiotic resistance evolution
Marta Lukacisinova et al.
CURRENT OPINION IN BIOTECHNOLOGY (2017)
The zinc cluster proteins Upc2 and Ecm22 promote filamentation in Saccharomyces cerevisiae by sterol biosynthesis-dependent and -independent pathways
Kelly Woods et al.
MOLECULAR MICROBIOLOGY (2016)
Experimental evolution in fungi: An untapped resource
Kaitlin J. Fisher et al.
FUNGAL GENETICS AND BIOLOGY (2016)
Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 system
Ludovic Enkler et al.
SCIENTIFIC REPORTS (2016)
Genetic Drivers of Multidrug Resistance in Candida glabrata
Kelley R. Healey et al.
FRONTIERS IN MICROBIOLOGY (2016)
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Dominique Sanglard
FRONTIERS IN MEDICINE (2016)
Filamentation protects Candida albicans from amphotericin B-induced programmed cell death via a mechanism involving the yeast metacaspase, MCA1
David J. Laprade et al.
MICROBIAL CELL (2016)
Mechanisms of echinocandin antifungal drug resistance
David S. Perlin
ANTIMICROBIAL THERAPEUTICS REVIEWS (2015)
Implication of Candida parapsilosis FKS1 and FKS2 Mutations in Reduced Echinocandin Susceptibility
M. Marti-Carrizosa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method
Shallu Kathuria et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
Xiao-Hui Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families
Valmik K. Vyas et al.
SCIENCE ADVANCES (2015)
Positions and Numbers of FKS Mutations in Candida albicans Selectively Influence In Vitro and In Vivo Susceptibilities to Echinocandin Treatment
M. Lackner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Glutathione Metabolism in Candida albicans Resistant Strains to Fluconazole and Micafungin
Bruno Maras et al.
PLOS ONE (2014)
Pooled Segregant Sequencing Reveals Genetic Determinants of Yeast Pseudohyphal Growth
Qingxuan Song et al.
PLOS GENETICS (2014)
Candida auris-Associated Candidemia, South Africa
Rindidzani E. Magobo et al.
EMERGING INFECTIOUS DISEASES (2014)
Molecular Mechanisms of Drug Resistance in Clinical Candida Species Isolated from Tunisian Hospitals
Jamel Eddouzi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence
Hui-Ching Ko et al.
JOURNAL OF MICROBIOLOGY (2013)
Effect of Amphotericin B on the Metabolic Profiles of Candida albicans
YingYing Cao et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Benjamin Matteson Vincent et al.
PLOS BIOLOGY (2013)
Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in ERG11 and Exhibiting Cross-Resistance to Azoles and Amphotericin B
Claire M. Hull et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Two Clinical Isolates of Candida glabrata Exhibiting Reduced Sensitivity to Amphotericin B Both Harbor Mutations in ERG2
Claire M. Hull et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
An improved allele-specific PCR primer design method for SNP marker analysis and its application
Jing Liu et al.
PLANT METHODS (2012)
New Fks Hot Spot for Acquired Echinocandin Resistance in Saccharomyces cerevisiae and Its Contribution to Intrinsic Resistance of Scedosporium Species
Michael E. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
CNVnator: An approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing
Alexej Abyzov et al.
GENOME RESEARCH (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst
Fernanda Sangalli-Leite et al.
MICROBES AND INFECTION (2011)
Microarray and Molecular Analyses of the Azole Resistance Mechanism in Candida glabrata Oropharyngeal Isolates
Huei-Fung Tsai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance
Alicia J. Zimbeck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing
Huiping Wang et al.
BMC MICROBIOLOGY (2009)
Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation
Dominique Sanglard et al.
FEMS YEAST RESEARCH (2009)
Candida auris sp nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital
Kazuo Satoh et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1
Anna Selmecki et al.
MOLECULAR MICROBIOLOGY (2008)
Role of DNA mismatch repair and double-strand break repair in genome stability and antifungal drug resistance in Candida albicans
Melanie Legrand et al.
EUKARYOTIC CELL (2007)
Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates
Alix Coste et al.
EUKARYOTIC CELL (2007)
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth
Patrick Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pdr1 regulates multidrug resistance in Candida glabrata:: gene disruption and genome-wide expression studies
John-Paul Vermitsky et al.
MOLECULAR MICROBIOLOGY (2006)
Role of γ-glutamyltranspeptidase in detoxification of xenobiotics in the yeasts Hansenula polymorpha and Saccharomyces cerevisiae
Vira M. Ubiyvovk et al.
CELL BIOLOGY INTERNATIONAL (2006)
The Flo8 transcription factor is essential for hyphal development and virulence in Candida albicans
F Cao et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans
TT Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of candida albicans ABC transporters CDR1 and CDR2
AT Coste et al.
EUKARYOTIC CELL (2004)
Apoptosis-like yeast cell death in response to DNA damage and replication defects
WC Burhans et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2003)
Yeast Rad17/Mec3/Ddc1: A sliding clamp for the DNA damage checkpoint
J Majka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Utilization of glutathione as an exogenous sulfur source is independent of γ-glutamyl transpeptidase in the yeast Saccharomyces cerevisiae:: evidence for an alternative gluathione degradation pathway
C Kumar et al.
FEMS MICROBIOLOGY LETTERS (2003)
Share Paper
